Crossmark

Golimumab in inflammatory bowel diseases: present and future scenarios

Crossref DOI link: https://doi.org/10.1007/s12328-018-0906-9

Published Online: 2018-09-11

Published Print: 2019-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Dragoni, Gabriele https://orcid.org/0000-0001-5752-5113
Le Grazie, Marco

Orlandini, Beatrice

Rogai, Francesca
License Information

Text and Data Mining valid from 2018-09-11
More Information

Article History

Received: 16 May 2018

Accepted: 23 August 2018

First Online: 11 September 2018

Compliance with ethical standards

:

: Gabriele Dragoni, Marco Le Grazie, Beatrice Orlandini and Francesca Rogai declare that they have no conflict of interest.

: All procedures followed have been performed in accordance with the ethical standards laid 　dowm in the 1964 Declaration of Helsinki and its later amendments.

: Informed consent was obtained from all patients for being included in the study.